New MS drug trial uses Super-Powered MRI to see inside the brain
Disease control
Not yet recruiting
This study tests an experimental drug called remibrutinib in 20 people with relapsing or progressive multiple sclerosis (MS). Participants take the drug twice daily for 2 years and undergo powerful 7T MRI scans to measure changes in brain volume, lesions, and tissue health. The g…
Phase: PHASE2 • Sponsor: Moein Amin • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC